Sep 4, 2026 · 1 hr 7 min · 12 segments
In this episode, Host Tom Salemi sits down with Eliane Schutte, CEO of Xeltis, to discuss a remarkable biomaterial designed to help the body grow its own living blood vessels. Schutte explains how the…
Eliane SchutteGuest
Tom SalemiHost
Katie GrantGuest
Chris NewmarkerHost
We'll open up with Chris Neumarker and the Neumarker's Newsmakers, the top news from mass device.
She is the CEO of Zeltis, which is a very cool, cool company that's built an artificial sort of scaffold that will help the body grow blood vessels.
So they've got some early applications in commercial stage indications for dialysis.
for folks who are receiving dialysis, but some other bigger plans that you can certainly hear in the interview, which happens at the last third, the later third of the podcast.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.
We'll open up with Chris Neumarker and the Neumarker's Newsmakers, the top news from mass device.
She is the CEO of Zeltis, which is a very cool, cool company that's built an artificial sort of scaffold that will help the body grow blood vessels.
So they've got some early applications in commercial stage indications for dialysis.
for folks who are receiving dialysis, but some other bigger plans that you can certainly hear in the interview, which happens at the last third, the later third of the podcast.